News
AbbVie and Eli Lilly snub drug pricing agreement
Global pharma giants, AbbVie and Eli Lilly and Company (Lilly), have shocked the UK Government by leaving the voluntary medicines pricing agreement. The move is a response to increasingly punishing revenue clawbacks.